Neoss Group, a leading innovator in dental implant solutions, is proud to announce that it has received EU Medical Device Regulation (MDR) certification by its Notified Body, the BSI Group, the Netherlands B.V. for its implants and abutments. ...
Sigrid Therapeutics announces the commencement of the SHINE clinical trial for SiPore21® – an innovative medical device designed for sustained diabetes and weight control. Based on Mesoporous Silica particles (MSPs), SiPore21® represents a groundbreaking approach to managing these pressing health concerns. Administered orally in gel form, MSPs act as "molecular sieves," physically preventing digestive enzymes from interacting with food, thereby reducing the breakdown of carbohydrates and fats....
To identify patients with the MSI biomarker who may be eligible for potential treatment with Jemperli ...
Strategically positioned to accelerate growth and expand presence in key markets across the United States, Europe, and the Asia-Pacific region...
Project launched with Jikei University School of Medicine aiming for early detection of osteoporosis ...
Lunit's 6 posters unveil new tumor microenvironment insights and the predictive power of Lunit SCOPE across diverse cancer types at SITC 2023...
Company Continues to Build Momentum with Most Recent Portfolio Expansion....
Patients implanted with the Evoke® System now eligible for full-body MRI scans...
Fujitsu Limited and iSurgery Co., Ltd. announced that they will conduct a field trial as part of their “bone health promotion project” from October 2023 to March 2025 in collaboration with the Department of Orthopaedic Surgery at the Jikei University School of Medicine (1), to verify the practicality of bone assessments (2) conducted with chest radiographs and the effects of this approach in changing Fujitsu employees’ attitudes and habits around health. This marks the first time in Japan that ...
Partnership acknowledges the increasing mental health challenges faced by students...
